Tom Baker Cancer Centre declines donation from cannabis club
Cannabis gave him as much of his life back as he could have in the later stages
Medical Cannabis Australia is now exporting to Germany
“For MCA to play such an important role in the advancement of cannabis-related medicine is a professional milestone, certainly, and an even greater personal reward,”
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options, especially for the progressive forms of the disease. Both preclinical and clinical data suggest that cannabinoids, derived from the Cannabis sativa plant, may be used to control symptoms such as spasticity and chronic pain.
Dirty Water Organic Seeds – Peezy Does It
The company was formed out of his love and passion for the plant
“Outdoor VS Indoor” Words and Photos by: Mendo Dope
There is a very small percentage of the world that can grow perfect outdoor cannabis.
Power to the people with the 25% THC of Gorilla Girl® and the one hit madness of Sweet Amnesia Haze® by Sweet Seeds
Sweet Seeds® recently released two super powerful strains: Gorilla Girl® (Sweet Seeds® variety SWS74) and Sweet Amnesia Haze® (SWS72).
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease
Cannabis can alleviate pain of various etiologies. This study assessed the effect of cannabis on motor symptoms and pain parameters in patients with Parkinson’s disease (PD).Cannabis improved motor scores and pain symptoms in PD patients, together with a dissociate effect on heat and cold pain thresholds. Peripheral and central pathways are probably modulated by cannabis.
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
Cannabis sativa active compounds are extensively studied for their therapeutic effects, beyond the well-known psychotropic activity. C. Sativais used to treat different medical indications, such as multiple sclerosis, spasticity, epilepsy, ulcerative colitis and pain. In this review, we will consider the structure-activity relationship (SAR) of cannabinoid compounds able to bind to cannabinoid receptors and act as therapeutic agents in neuronal diseases, e.g., Parkinson’s disease.
Endocannabinoids in arthritis: current views and perspective
Preclinical and clinical studies using cannabis-based therapy have been shown to provide both analgesia and anti-inflammatory effects, with an overall alleviation of clinical symptoms in animal models of arthritis, highlighting its promising therapeutic application for humans.
Issues and promise in clinical studies of botanicals with anticonvulsant potential
Botanicals are increasingly used by people with epilepsy worldwide. Although the currently available evidence for the use of cannabinoids in epilepsy is similarly lacking, several carefully designed and well controlled industry-sponsored clinical trials of cannabis derivatives are planned to be completed in the next couple of years, providing the needed reliable data for the use of these products.
